Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.02T | 2.00T | 2.03T | 1.84T | 1.53T | 1.60T | Gross Profit |
562.61B | 553.11B | 564.94B | 513.64B | 406.95B | 441.17B | EBIT |
88.20B | 92.92B | 128.52B | 148.91B | 70.64B | 100.19B | EBITDA |
272.88B | 220.12B | 334.04B | 330.66B | 228.81B | 243.13B | Net Income Common Stockholders |
100.48B | 101.07B | 127.99B | 148.41B | 90.21B | 107.72B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
606.93B | 460.33B | 396.90B | 458.21B | 484.08B | 493.65B | Total Assets |
3.02T | 4.47T | 4.09T | 3.92T | 3.49T | 3.25T | Total Debt |
8.14B | 304.19B | 209.80B | 149.26B | 147.82B | 127.32B | Net Debt |
-408.11B | -120.60B | -163.70B | -264.87B | -238.91B | -292.30B | Total Liabilities |
628.13B | 1.21T | 1.05T | 1.02T | 877.36B | 795.93B | Stockholders Equity |
2.30T | 3.23T | 3.02T | 2.87T | 2.59T | 2.43T |
Cash Flow | Free Cash Flow | ||||
101.90B | 109.33B | -7.43B | 55.05B | 88.69B | 93.90B | Operating Cash Flow |
253.90B | 269.07B | 179.21B | 201.96B | 220.82B | 214.63B | Investing Cash Flow |
-158.30B | -158.41B | -168.83B | -79.46B | -183.79B | -145.55B | Financing Cash Flow |
-99.02B | -82.60B | -61.26B | -111.47B | -80.97B | -157.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $16.43B | 88.46 | 0.86% | 2.18% | -6.70% | -73.25% | |
62 Neutral | $8.16B | 12.85 | 0.64% | 3.04% | 3.83% | -15.83% | |
61 Neutral | $26.98B | 10.77 | 84.33% | 3.72% | 1.03% | -18.56% | |
54 Neutral | $1.67B | 163.81 | 35.20% | 2.29% | -19.20% | ― | |
44 Neutral | $296.16M | ― | -87.12% | ― | 5.59% | 32.06% | |
43 Neutral | $765.47M | ― | -65.36% | 15.97% | -9.70% | -5576.16% |